Vascular Stents Market 2022
Vascular stents are tiny tube like medical devices which are places into blood vessels or arteries to open the blockage in the vessels. Vascular stent is the valuable tool for the treatment of the different coronary diseases. Vascular stents are used to widen the narrow vessels so as to minimize the chances of heart attack and chest pain. This stents are prepared from variety of material. According to the WHO, approximately 18 million people died from cardiovascular diseases in 2014. Increasing number of people suffering from cardiovascular diseases is responsible for the driving the market. Additionally, globally 39% of adults aged 18 years and over were overweight whereas 13% were obese. Technological advances and increasing obese population is also contributed in the growth of the market. Other advantages like low risk of infection and short recovery time will also drive the market. However availability of alternative therapy and high cost of ventricular stents may restrain the growth of the market.
Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/1408
Major Key Players:
Boston Scientific Corporation (US), Abbott Laboratories (US), Medtronic, Plc (UK), Cook Medical (US), Biotronik se & co. kg (Germany), B. Braun Melsungen AG (Germany), Cordis (US), Lombard Medical Technologies (UK), Translumina GmbH (Germany), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Vascular Concepts (India), W.L. Gore & Associates (US), Meril Life Sciences Pvt. Ltd. (India) are some of the prominent players at the forefront of competition in the Global Vascular Stents Market and are profiled in MRFR Analysis.
Many companies are focusing on research and development activity to improve the vascular stent products. Major companies are focusing on the development of biodegradable stents to overcome the disadvantages of other available stents. Some major has adopted strategies of acquisitions and strategic alliances for the growth of the market.
Abbott Laboratories is one of the leading healthcare company headquartered in US. In June 2016, FDA has approved the Absorb bioresorbable Stent for heart. This stents is completely dissolve in the body and used in the treatment of heart complications. Company’s Esprit bioresorbable vascular scaffold is under clinical trials.
December, 2016 – Lombard Medical and MicroPort Scientific Corporation announced strategic partnership and investment agreement. This partnership allowed Lombard Medical to accelerate commercialization in global market with its two key products i.e Aorfix and Altura AAA. Aorfix, the only stent graft to hold global approvals to treat abdominal aortic aneurysms (AAA) with aortic neck angles up to 900, and Altura, a highly innovative stent graft that offers a simple and predictable treatment option for standard abdominal aortic aneurysms anatomy.
Boston Scientific Corporation is a global manufacturer and developer of medical devices headquartered in US. PROMUS Element Plus Stent, REBEL Stent System, SYNERGY Stent are some of the major products of the company. In 2014, company has launched Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Asia Pacific region. In 2015, worldwide sales of the company’s drug-eluting coronary stents were $1.074 billion as compared to $1.151 billion during 2014.
Medtronic is a medical device manufacturer headquartered in UK. It is the world’s largest standalone medical technology development company. In 2015 company has develop Stent Graft System System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms. Earlier company’s Resolute Drug-Eluting Stent has shown a very good performance in Diabetic Patients with Heart Disease. Medtronic market was increased by 7% in 2016 compared to 2015.
Cook Medical is an US headquartered company involved in the manufacturing of the medical devices. Approach, Bird’s Nest, Advance are some of the major product of the company.
Geographically, the global Vascular Stents Market Size is segmented into four regions. Of which North America commands market for vascular stents due to increasing obese population in North America is the major factor for the growth of the market. Beside this increasing people suffering from various cardiovascular diseases and lack of exercise also contributed in the growth of the market. Europe accounts second largest Vascular Stents Market Share. While Asia Pacific is the fastest growing market due to rapid development in technology and a huge patient suffering from different vascular diseases. However, The Middle East and Africa has the lowest market for medical robotics because of limited development in medical field.
Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/vascular-stents-market-1408
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.
Related [email protected]
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312
Email: [email protected]